LONDON (dpa-AFX) - Moderna, Inc. (MRNA) Friday said the UK Court of Appeal has ruled that Moderna's EP'949 patent is valid and infringed by Pfizer/ BioNTech.
This decision upholds the High Court's initial ruling in July 2024 that the EP'949 patent was valid and infringed by Pfizer/ BioNTech's COVID-19 vaccine, Comirnati.
European patent EP'949 covers chemically modified mRNA, one of Moderna's core technologies used in the development of mRNA-based drugs.
In 2022, Moderna had sued Pfizer and BioNTech for patent infringement related to their COVID-19 vaccines, alleging they copied Moderna's mRNA technology.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
